<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Malar.</journal-id>
<journal-title>Frontiers in Malaria</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Malar.</abbrev-journal-title>
<issn pub-type="epub">2813-7396</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmala.2025.1612068</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Malaria</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: PRONet Duo insecticide-treated net incorporated with chlorfenapyr and bifenthrin is superior to Interceptor<sup>&#xae;</sup> G2 nets against pyrethroid-resistant <italic>Anopheles gambiae sensu lato</italic>: a randomized experimental hut trial in C&#xf4;te d&#x2019;Ivoire and Tanzania using non-inferiority design</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Assenga</surname>
<given-names>Alphonce A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2910686/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ahoua Alou</surname>
<given-names>Ludovic P.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2647716/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Camara</surname>
<given-names>Soromane</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koffi</surname>
<given-names>Alphonsine A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>N&#x2019;Guessan</surname>
<given-names>Raphael</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kamande</surname>
<given-names>Dismas S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ngonyani</surname>
<given-names>Safina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kibondo</surname>
<given-names>Ummi A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Odufuwa</surname>
<given-names>Olukayode G.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2905327/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ntabaliba</surname>
<given-names>Watson S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lekundayo</surname>
<given-names>Ruth G.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abilah</surname>
<given-names>Faraji</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Madumla</surname>
<given-names>Edith P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Muganga</surname>
<given-names>Joseph B.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moore</surname>
<given-names>Jason</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2953444/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moore</surname>
<given-names>Sarah J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1892072/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Vector Control Product Testing Unit (VCPTU), Environmental Health and Ecological Sciences, Ifakara Health Institute</institution>, <addr-line>Bagamoyo</addr-line>, <country>Tanzania</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Vector Control Product Evaluation Centre (VCPEC), Institut Pierre Richet/Institut National de Sant&#xe9; Publique</institution>, <addr-line>Bouak&#xe9;</addr-line>, <country>C&#xf4;te d&#x2019;Ivoire</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Disease Control, London School of Hygiene and Tropical Medicine</institution>, <addr-line>London</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute</institution>, <addr-line>Allschwil</addr-line>, <country>Switzerland</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>University of Basel</institution>, <addr-line>Basel</addr-line>, <country>Switzerland</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>The Nelson Mandela African Institution of Science and Technology (NM-AIST)</institution>, <addr-line>Tengeru</addr-line>, <country>Tanzania</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Louisa Alexandra Messenger, University of Nevada, Las Vegas, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Alphonce A. Assenga, <email xlink:href="mailto:aassenga@ihi.or.tz">aassenga@ihi.or.tz</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>05</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>3</volume>
<elocation-id>1612068</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>04</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Assenga, Ahoua Alou, Camara, Koffi, N&#x2019;Guessan, Kamande, Ngonyani, Kibondo, Odufuwa, Ntabaliba, Lekundayo, Abilah, Madumla, Muganga, Moore and Moore</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Assenga, Ahoua Alou, Camara, Koffi, N&#x2019;Guessan, Kamande, Ngonyani, Kibondo, Odufuwa, Ntabaliba, Lekundayo, Abilah, Madumla, Muganga, Moore and Moore</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front Malar" journal-id-type="nlm-ta" xlink:href="10.3389/fmala.2025.1540884" ext-link-type="doi">A Corrigendum on <article-title>PRONet Duo insecticide-treated net incorporated with chlorfenapyr and bifenthrin is superior to Interceptor&#xae; G2 nets against pyrethroid-resistant <italic>Anopheles gambiae sensu lato</italic>: a randomized experimental hut trial in C&#xf4;te d&#x2019;Ivoire and Tanzania using non-inferiority design</article-title> by Assenga AA, Ahoua Alou LP, Camara S, Koffi AA, N&#x2019;Guessan R, Kamande DS, Ngonyani S, Kibondo UA, Odufuwa OG, Ntabaliba WS, Lekundayo RG, Abilah F, Madumla EP, Muganga JB, Moore J and Moore SJ (2025). <italic>Front. Malar</italic>. 3:1540884. doi:&#xa0;<object-id>10.3389/fmala.2025.1540884</object-id>
</related-article>
<kwd-group>
<kwd>
<italic>Anopheles gambiae</italic>
</kwd>
<kwd>
<italic>Anopheles coluzzii</italic>
</kwd>
<kwd>
<italic>Anopheles arabiensis</italic>
</kwd>
<kwd>non-inferiority</kwd>
<kwd>chlorfenapyr</kwd>
<kwd>bifenthrin</kwd>
<kwd>PRONet Duo</kwd>
<kwd>Interceptor<sup>&#xae;</sup>&#xa0;G2</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="189"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Vectors</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In the published article, there was an error in <xref ref-type="table" rid="T1">
<bold>
<bold>Table&#xa0;1</bold>
</bold>
</xref> as published. The mistake was in the description of the active ingredients of Interceptor&#xae; G2 which was incorrectly described as containing Alpha cypermethrin 4.8g/kg (200 mg/m2) and Chlorfenapyr 2.4 g/kg (100 mg/m2). The corrected <xref ref-type="table" rid="T1">
<bold>
<bold>Table&#xa0;1</bold>
</bold>
</xref> and its caption appear below.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Description of net products used in the experiment.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Net Type</th>
<th valign="top" align="left">Fibre</th>
<th valign="top" align="left">Active Ingredient</th>
<th valign="top" align="left">Role</th>
<th valign="top" align="left">Manufacturer</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<bold>PRONet Duo</bold>
</td>
<td valign="top" align="left">High density polyethylene (HDPE) incorporated 120 denier</td>
<td valign="top" align="left">Bifenthrin 7g/kg<break/>Chlorfenapyr 8g/kg</td>
<td valign="top" align="left">Investigational item</td>
<td valign="top" align="left">VKA Polymers India</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Interceptor&#xae; G2</bold>
</td>
<td valign="top" align="left">Multifilament polyester<break/>Coated 100 denier</td>
<td valign="top" align="left">Alpha cypermethrin 2.4 g/kg (100 mg/m<sup>2</sup>)<break/>Chlorfenapyr 4.8 g/kg (200 mg/m<sup>2</sup>)</td>
<td valign="top" align="left">Active comparator</td>
<td valign="top" align="left">BASF SE, Germany</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>MAGNet&#xae;</bold>
</td>
<td valign="top" align="left">HDPE incorporated<break/>150 denier</td>
<td valign="top" align="left">Alpha cypermethrin 5.8g/kg</td>
<td valign="top" align="left">Standard comparator</td>
<td valign="top" align="left">VKA Polymers, India</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Negative control</bold>
</td>
<td valign="top" align="left">Polyester net</td>
<td valign="top" align="left">Untreated Tanzania</td>
<td valign="top" align="left">Negative control</td>
<td valign="top" align="left">A to Z, Tanzania</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Negative control</bold>
</td>
<td valign="top" align="left">Polyethylene net</td>
<td valign="top" align="left">Untreated C&#xf4;te d&#x2019;Ivoire</td>
<td valign="top" align="left">Negative control</td>
<td valign="top" align="left">VKA Polymers, India</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec id="s2" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>